For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows. Photo by Adobe Stock/HealthDay News Drugs already taken by millions of ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

Trials of a new asthma drug show that it could prove life changing for many people – who would only need two jabs a year. The ...

A study published in JAMA found GLP-1 medications helped relieve symptoms of obesity-related asthma. Children taking them had ...

The price of asthma medication has soared in the U.S. over the past decade and a half. I’m a health law professor at Villanova University, where I study whether patients can get the medicines they ...

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

Advisers to the Food and Drug Administration have recommend that drugs Serevent and Foradil no longer be used for asthma. Top-selling Advair was not affected by the recommendation. There is news today ...

An advisory committee to the Food and Drug Administration says one type of a long-acting asthma medication has more benefits than risks, but another type has more risks than benefits. The decision may ...

To survive and replicate inside our cells, a virus has to be able to adapt them to its own advantage. This means altering the cells’ metabolism, physiology, and gene expression. Often, these ...